diabetes-2019-posters-abstracts

9 / 9

Page 50
Joint Event
November 29-30, 2019 | Frankfurt, Germany
28th International Conference on 3rd International Conference on
Diabetes and Endocrinology Diabetes and Metabolism &
2
0
1
9 CONGRESS
DIABETES
2019
DIABETES
Journal of Endocrine Disorders & Surgery | Volume 3
Ethnobotanical and ethnotherapeutic investigations on plant species used in the
treatment of T2D in Guinean traditional medicine
F Bah, E S Baldé, M S Traoré, A O Baldé, NM Baldé, T O Kéita, D Dioubaté, A Camara, A D Doumbouya, A L Minthé,
M A Diallo, F M Camara, L Diallo and A M Baldé
Institut de Recherche et de Développement des Plantes Médicinales et Alimentaires de Guinée, Guinée
As in other sub-Saharan Africa countries, the majority of
Guinean population depend on traditional and herbal
medicines, for their healthcare needs. Although traditional
medicine knowledge have been passed on orally among
traditional health practioners for many generations, concern
has been often raised about the effectiveness and security
of their remedies. Aiming to improve the health conditions
of the populations through a rational use of the Guinean
Pharmacopea and Traditional Medicine, an ethnobotanical
Investigation, an ethnobotanical Investigation conducted in
the middle and coastal lowlands of Guinea made it possible
to contact 198 traditional healers, 108 herbalists and 397
diabetic patients. An inventory of 188 identified plant species
belonging to 55 botanical families was made.
Based on their quotation over healers, herbalists and
consumers, based also on their distribution, longtime use, 8
plant species were selected viz Englerina lecardii, Combretum
glutinosum, Ficus glumosa, Jatropha gossypifolia, Anacardium
occidentale, Hymenocardia acida, Bauhinia thonningii,
Spathodea campanulata. When subjected to ethnotherapeutic
evaluation on volunteer patients for a period of 2 to 6 months,
slight, modest and significant declines in fasting blood sugar
were recorded, depending on the species. The lowest blood
sugar (2.14 from the baseline to 1.15 g/L at the end of
treatment) were recordedwith patients treatedwith he extract
of « Sattagas ». Upon consideration of these results, Guinean
medicinal plant species may constitute a source of new
bioactive molecules for the management of type2 diabetes.
e:
Notes: